571 related articles for article (PubMed ID: 24483293)
21. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
22. Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
Tan DCT; Khong YM; Mount S; Galella E; Mitra B; Charlton S; Kuhli M; Ternik R; Walsh J; Rajapakshe A; Thompson K; Mehrotra S; Santangelo M; Liu J; Dixit T; Schaufelberger D; Jamzad S; Klein S; Hoag SW; Wang J; Fletcher EP; Khurana M; Alexander J; Radden E; Sood R; Selen A
Eur J Pharm Biopharm; 2021 Jul; 164():54-65. PubMed ID: 33878432
[TBL] [Abstract][Full Text] [Related]
23. Issues impacting therapeutic outcomes in pediatric patients: an overview.
Kalra A; Goindi S
Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
[TBL] [Abstract][Full Text] [Related]
24. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
25. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
26. Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.
Rivera DR; Hartzema AG
Ann Pharmacother; 2014 Mar; 48(3):369-79. PubMed ID: 24311725
[TBL] [Abstract][Full Text] [Related]
27. Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.
Walsh J; Ranmal SR; Ernest TB; Liu F
Int J Pharm; 2018 Feb; 536(2):547-562. PubMed ID: 28705619
[TBL] [Abstract][Full Text] [Related]
28. Reflection on the Pharmaceutical Formulation Challenges Associated with a Paediatric Investigation Plan for an Off-Patent Drug.
Walsh J
AAPS PharmSciTech; 2017 Feb; 18(2):250-256. PubMed ID: 27097815
[TBL] [Abstract][Full Text] [Related]
29. FDA: contribution to developing pediatric formulations and transatlantic collaboration.
Khan MA; Wu K; Gupta A
Int J Pharm; 2012 Oct; 435(2):146-8. PubMed ID: 22883702
[No Abstract] [Full Text] [Related]
30. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
31. Developing early formulations: practice and perspective.
Li P; Zhao L
Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
[TBL] [Abstract][Full Text] [Related]
32. Challenges of pediatric formulations: a FDA science perspective.
Gupta A; Khan MA
Int J Pharm; 2013 Nov; 457(1):346-8. PubMed ID: 24216242
[No Abstract] [Full Text] [Related]
33. Oral transmucosal drug delivery for pediatric use.
Lam JK; Xu Y; Worsley A; Wong IC
Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
[TBL] [Abstract][Full Text] [Related]
34. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
[No Abstract] [Full Text] [Related]
35. Failed Pediatric Drug Development Trials.
Momper JD; Mulugeta Y; Burckart GJ
Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
[TBL] [Abstract][Full Text] [Related]
36. Stable isotope-labeled excipients for drug product identification and counterfeit detection.
Felton LA; Shah PP; Sharp Z; Atudorei V; Timmins GS
Drug Dev Ind Pharm; 2011 Jan; 37(1):88-92. PubMed ID: 20560792
[TBL] [Abstract][Full Text] [Related]
37. Practical considerations in development of solid dosage forms that contain cyclodextrin.
Miller LA; Carrier RL; Ahmed I
J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
[TBL] [Abstract][Full Text] [Related]
38. Liquisolid systems and aspects influencing their research and development.
Vraníková B; Gajdziok J
Acta Pharm; 2013 Dec; 63(4):447-65. PubMed ID: 24451071
[TBL] [Abstract][Full Text] [Related]
39. Basics of Compounding with Dilutions and Concentrates.
Allen LV
Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197
[TBL] [Abstract][Full Text] [Related]
40. A new design for the review and appraisal of semi-solid dosage forms: Semi-solid Control Diagram (SSCD).
Nardi-Ricart A; Linares MJ; Villca-Pozo F; Pérez-Lozano P; Suñé-Negre JM; Bachs-deMiquel L; Roig-Carreras M; Suñé-Pou M; Nofrerias-Roig I; García-Montoya E
PLoS One; 2018; 13(9):e0201643. PubMed ID: 30192759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
